Gina Wentling   Posted in News    Aug 25th, 2017

Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics

Dr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy.

Read the full press release.